According to the research report titled ‘Bone Grafts and Substitutes Market Size, Share & Trends Analysis Report By Material Type; By Application Type; By Region - Segment Forecast, 2020 – 2026’ available with Market Study Report, global bone grafts and substitutes market valuation is anticipated to account for around USD 4.15 billion by the year 2026.
 

Factors such as increasing adoption of bone grafting processes, growing geriatric population, escalating demand for high-quality musculoskeletal function, and rising penetration of specialty orthopedic clinics are augmenting the growth of global bone grafts and substitutes market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2963748/
 

For the record, bone grafts are bone grafting is a surgical procedure that is carried out for bone regeneration for restoring the structure and relieving pain. Autologous bone grafts are primarily used for the procedures and are regarded as the gold standard for bone transplant.
 

Additionally, surging adoption of organic and natural products, increasing disposable income in developing countries, technological advancements, rising prevalence of musculoskeletal illnesses, and rapid urbanization are stimulating the global bone grafts and substitutes market outlook.
 

Furthermore, increasing accessibility of a wide variety of allografts coupled with escalating demand for bone grafts are positively swaying the market dynamics. However, high costs, risks, and complications associated with the bone grafts procedures along with deceptive marketing strategies are expected to hamper the industry expansion throughout the analysis timeframe.
 

Based on material type, global bone grafts and substitutes industry is bifurcated into synthetic and natural. With regards to application landscape, the market comprises of long bone, craniomaxillofacial, and spinal fusion.
 

From a regional point of view, North America is predicted to emerge as a major revenue generator for global bone grafts and substitutes industry during 2020-2026. Surging demand for bone graft procedures in the U.S., increasing occurrence of trauma-related accidents, and rising prevalence of osteoarthritis as well as orthopedic ailments are fostering the growth of the regional market.
 

Alternatively, Europe bone grafts and substitutes industry is estimated to grow substantially through 2026, owing to high concentration of major players along with rising demand for technologically advanced and innovative therapies in the region.
 

Leading organizations that define the global bone grafts and substitutes industry trends are BIObank, TBF Génie Tissulaire, Geistlich Pharma AG, Zimmer Biomet, Wright Medical Group N.V., Baxter International Inc., Smith & Nephew plc, AlloSource, NuVasive, Inc., Stryker Corporation, Medtronic PLC, DePuy Synthes, Inc., and Orthofix Holdings, Inc.